Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

ISR Immune System Regulation

Less than 1K followers
All
Webcasts
Press releases
ShowingAll content types
Regulatory press release8/28/2023, 10:01 AM

ISR's, SARS-CoV-2 dry powder nasal - vaccine booster candidate, ISR52, demonstrates superior immune response, in mouse model challenge studies compared to subcutaneous injection of this vaccine.

ISR Immune System Regulation
ISR, Audiocast with teleconference, Half-year report 2022
Webcast9/1/2022, 8:30 AM

ISR, Audiocast with teleconference, Half-year report 2022

ISR Immune System Regulation
Regulatory press release7/1/2022, 8:20 AM

ISR: SARS-CoV-2 vaccine study approved by Bangladesh BMRC

ISR Immune System Regulation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release6/28/2022, 1:00 PM

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR Immune System Regulation
Regulatory press release6/28/2022, 1:00 PM

ISR signs development agreements with Catalent to scale-up its spray-dried nasal vaccine, powder formulation for Phase III.

ISR Immune System Regulation
Regulatory press release6/20/2022, 1:45 PM

Delegation from Bangladesh visits ISR for study preparation

ISR Immune System Regulation
Press release5/5/2022, 5:35 AM

Redeye: Redeye Initiates Coverage of ISR Holding

ISR Immune System Regulation
ISR, Audiocast with teleconference, Year-end Report, 2021
Webcast2/23/2022, 12:00 PM

ISR, Audiocast with teleconference, Year-end Report, 2021

ISR Immune System Regulation
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.